Literature DB >> 16880713

Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease.

Mitja Lainscak, Stefan Andreas, Paul D Scanlon, Virend K Somers, Stefan D Anker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16880713     DOI： 10.2169/internalmedicine.45.1867

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


× No keyword cloud information.
  10 in total

Review 1.  [Percutaneous aortic valve replacement - pro].

Authors:  Lutz Buellesfeld; Eberhard Grube
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

2.  COPD is not COPD is not allergy.

Authors:  Stanislav Suskovic
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.

Authors:  Mitja Lainscak; Lea Majc Hodoscek; Hans-Dirk Düngen; Mathias Rauchhaus; Wolfram Doehner; Stefan D Anker; Stephan von Haehling
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 4.  Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review.

Authors:  Wolfram Doehner; Stephan von Haehling; Stefan D Anker; Mitja Lainscak
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

5.  Feasibility of transcutaneous electrical muscle stimulation in acute exacerbation of COPD.

Authors:  Uros Meglic; Jure Sorli; Mitja Kosnik; Mitja Lainscak
Journal:  Wien Klin Wochenschr       Date:  2011-05-25       Impact factor: 1.704

Review 6.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

Review 7.  Current and potential roles of ghrelin in clinical practice.

Authors:  G Angelidis; V Valotassiou; P Georgoulias
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

8.  Ghrelin for cachexia.

Authors:  Takashi Akamizu; Kenji Kangawa
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

9.  Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia.

Authors:  Timo D Müller; Diego Perez-Tilve; Jenny Tong; Paul T Pfluger; Matthias H Tschöp
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

10.  Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Mitja Lainscak; Stephan von Haehling; Wolfram Doehner; Irena Sarc; Tina Jeric; Kristina Ziherl; Mitja Kosnik; Stefan D Anker; Stanislav Suskovic
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-03-01       Impact factor: 12.910
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.